ea0026p701 | Diabetes complications | ECE2011
Kuzuguden Cigdem
, Guldiken Sibel
, Ustundag Sedat
, Ozgen Zeren
, Demir Muzaffer
Aim: The aim of this study was to investigate the relationship between the clinical and laboratory findings of metabolic bone disease regarding the levels of osteoprotegerin (OPG) and the receptor activator of nuclear factor kappa B ligand (RANKL) in the patients with diabetic nephropathy.Material and method: This study includes 61 type 2 diabetic patients and age-, sex-matched 20 healthy subjects. Diabetic patients were divided into three groups accordi...